Source: Eur Respir J 2008; 32: 25-34
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
He, J-Q., Shumansky, K., Connett, J. E., Anthonisen, N. R., Pare, P. D., Sandford, A. J.. Association of genetic variations in the CSF2 and CSF3 genes with lung function in smoking-induced COPD. Eur Respir J 2008; 32: 25-34

Member's Comments

No comment yet.

Related content which might interest you: Polymorphisms of interleukin-10 and its receptor and lung function in COPD Source: Eur Respir J 2007; 29: 1120-1126 Year: 2007 Recovery of neutrophil apoptosis by ectoine: a new strategy against lung inflammation Source: Eur Respir J 2013; 41: 433-442 Year: 2013 Aerosol granulocyte-macrophage colony-stimulating factor for pulmonary alveolar proteinosis Source: Eur Respir J 2006; 27: 585-593 Year: 2006 Efficacy of aerosolized granulocyte-macrophage colony stimulating factor (GM-CSF) in a Japanese female patient with pulmonary alveolar proteinosis (PAP) Source: Eur Respir J 2001; 18: Suppl. 33, 221s Year: 2001 Tumour necrosis factor and lymphotoxin A polymorphisms and lung function in smokers Source: Eur Respir J 2007; 29: 34-41 Year: 2007 Plasmapheresis for treatment of pulmonary alveolar proteinosis Source: Eur Respir J 2009; 33: 1220-1222 Year: 2009 Association of VEGF polymorphisms with childhood asthma, lung function and airway responsiveness Source: Eur Respir J 2009; 33: 1287-1294 Year: 2009 Cytokines in chronic obstructive pulmonary disease Source: Eur Respir J 2001; 18: 50S-59S Year: 2001 Upregulation of basic fibroblast growth factor in smokers with chronic bronchitis Source: Eur Respir J 2006; 27: 957-963 Year: 2006 Correlation of IL-1 alpha and IL-4 promotor region gene polymorphisms and clinical parameters in idiopathic pulmonary fibrosis Source: Annual Congress 2006 - Systemic diseases, environmental and genetic factors in interstitial lung disease Year: 2006 Placenta growth factor (PlGF) triggers small airway remodeling (SAR) in chronic obstructive pulmonary disease (COPD) Source: International Congress 2017 – Insight into the pathogenesis of emphysema and pneumonia Year: 2017 Granulocyte-macrophage colony stimulating factor inhalation therapy as a treatment for pulmonary alveolar proteinosis Source: Eur Respir J 2003; 22: Suppl. 45, 377s Year: 2003 Measurement of tumor necrosis factor (TNF)α, leukotriene B4 (LTB4), and interleukin 8 (IL8) in the exhaled breath condensate (EBC) in patients with acute exacerbations of chronic obstructive pulmonary disease (AECOPD) Source: Eur Respir J 2007; 30: Suppl. 51, 584s Year: 2007 Association of the TNF gene promoter polymorphism with serum tumor necrosis factor-alpha levels in chronic obstructive pulmonary disease patients Source: Eur Respir J 2006; 28: Suppl. 50, 522s Year: 2006 High serum granulocyte-colony stimulating factor characterises neutrophilic COPD exacerbations associated with dysbiosis Source: ERJ Open Res, 7 (3) 00836-2020; 10.1183/23120541.00836-2020 Year: 2021 Hepatocyte growth factor (HGF) expression in bronchoveolar lower (BAL) does not confirm its anti-fibrotic activity in interstitial lung diseases (ILD) Source: Annual Congress 2012 - Idiopathic pulmonary fibrosis Year: 2012 Down regulation of stromal cell-derived factor 1 (SDF-1/CXCL12) in lung tissue of patients with idiopathic pulmonary fibrosis Source: Eur Respir J 2007; 30: Suppl. 51, 574s Year: 2007 Epidermal growth factor in the lungs of infants developing chronic lung disease Source: Eur Respir J 2001; 18: 796-800 Year: 2001 Leptin receptor polymorphisms and lung function decline in COPD Source: Eur Respir J 2009; 34: 103-110 Year: 2009 Transforming growth factor B1 polymorphism and serum levels in interstitial lung diseases Source: International Congress 2015 – New insights into IIPs Year: 2015